Joint Commission keeping clinician texting ban in place until September

After reversing a five-year-old ban on healthcare organizations sending orders via text in May, the Joint Commission has changed plans again, announcing in its June newsletter the previous ban won’t be lifted until September.

The commission said extra guidance is needed to “ensure a safe implementation involving the secure texting of orders” for organizations interested in using that kind of system.

“The Centers for Medicare & Medicaid Services (CMS) will collaborate with the Joint Commission on the development of additional guidance for text orders to ensure congruency with the Medicare Conditions of Participation,” the commission said. “The Joint Commission and CMS will develop a comprehensive series of frequently asked questions (FAQ) documents to assist healthcare organizations with the incorporation of text orders into their policies and procedures.”

The May update had included several suggestions for setting up a secure texting platform, such as a secure sign-on process and limiting who can receive and record the orders, but the commission had also said more detailed standards would have to be developed. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Cardiologists and other physicians may soon need to provide much more information when ordering remote patient monitoring for Medicare patients.

Why are so many cardiovascular devices involved in Class I recalls? One possible reason could be the large number of devices hitting the market without undergoing much premarket clinical testing. 

Trimed Popup
Trimed Popup